Triazole derivative and use thereof
AssigneeTakeda Pharmaceutical Company Limited
InventorsKeiji Kubo, Mamoru Tobisu, Eiji Honda, Takahiko Taniguchi, Yoshiyuki Fukase, Masaki Kawamura, Masaharu Nakayama
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Pharmaceutical Company Limited
InventorsKeiji Kubo, Mamoru Tobisu, Eiji Honda, Takahiko Taniguchi, Yoshiyuki Fukase, Masaki Kawamura, Masaharu Nakayama
Estimating the term…
The present invention relates to a thrombin receptor antagonist containing a compound represented by the formula (I) wherein R1a, R1b and R2 are each a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, or an optionally substituted alkoxy, R3 is a group represented by the formula —NHCOR4, —NHSO2R5, —NHCON(R6a)(R6b), —NHCOOR7 or —CONHR8 wherein R4, R5, R6a, R6b, R7 and R8 are each a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like), ring A is monocyclic aromatic ring optionally further having substituent(s), R1a and R1b are optionally bonded to each other to form an optionally substituted nitrogen-containing non-aromatic heterocycle, or a salt thereof or a prodrug thereof. The thrombin receptor antagonist of the present invention has a thrombin receptor (particularly PAR-1) antagonistic action and is useful for the prophylaxis or treatment of PAR-1 mediated pathological condition or disease.
A compound represented by the formula (I′)
Dependencies are inferred from the claim text.